Literature DB >> 11050069

No significant correlation exists between core promoter mutations, viral replication, and liver damage in chronic hepatitis B infection.

Y K Chun1, J Y Kim, H J Woo, S M Oh, I Kang, J Ha, S S Kim.   

Abstract

Hepatitis B virus (HBV) core promoter mutants have been proposed to contribute to severe liver damage by increasing viral loads, but this has not yet been clearly shown. To examine the effects of core promoter mutants on viral load and liver damage, we first developed a polymerase chain reaction (PCR)-based semiquantitative HBV DNA detection method with a high sensitivity (able to detect as low as 10(3) molecules/mL). Then we cloned 12 predominant core promoter mutants from 41 chronic hepatitis B patients. The in vitro promoter and replication activities of these mutants were similar to those of wild-type virus. However, viral load was highly variable, and this was dependent on individual patients rather than mutant type. In addition, there was no mutant type that showed any unique correlation with alanine transaminase (ALT) levels. Viral load was not significantly correlated with ALT level in both cross-sectional and longitudinal studies. Quantitation of HBV levels also revealed no clear correlation between hepatitis B e antigen (HBeAg) status and viral load. Taken together, these results indicated that the replication activity of core promoter mutants has little effect on viral load, and that viral load does not correlate with the severity of liver damage or with HBeAg status.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11050069     DOI: 10.1053/jhep.2000.19623

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  24 in total

1.  Relationship between body surface area and ALT normalization after long-term lamivudine treatment.

Authors:  Makoto Nakamuta; Shusuke Morizono; Yuichi Tanabe; Eiji Kajiwara; Junya Shimono; Akihide Masumoto; Toshihiro Maruyama; Norihiro Furusyo; Hideyuki Nomura; Hironori Sakai; Kazuhiro Takahashi; Koichi Azuma; Shinji Shimoda; Kazuhiro Kotoh; Munechika Enjoji; Jun Hayashi
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

2.  Temporal acquisition of sequential mutations in the enhancer II and basal core promoter of HBV in individuals at high risk for hepatocellular carcinoma.

Authors:  Xin Bai; Yu Zhu; Yan Jin; Xia Guo; Gengsun Qian; Taoyang Chen; Jing Zhang; Jinbing Wang; John D Groopman; Jianren Gu; Hong Tu
Journal:  Carcinogenesis       Date:  2010-09-28       Impact factor: 4.944

3.  Coexistence of hepatitis B virus quasispecies enhances viral replication and the ability to induce host antibody and cellular immune responses.

Authors:  Liang Cao; Chunchen Wu; Hui Shi; Zuojiong Gong; Ejuan Zhang; Hui Wang; Kaitao Zhao; Shuhui Liu; Songxia Li; Xiuzhu Gao; Yun Wang; Rongjuan Pei; Mengji Lu; Xinwen Chen
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

4.  Hepatitis B Virus Core Promoter A1762T/G1764A (TA)/T1753A/T1768A Mutations Contribute to Hepatocarcinogenesis by Deregulating Skp2 and P53.

Authors:  Jian Yan; Zhicheng Yao; Kunpeng Hu; Yuesi Zhong; Mingliang Li; Zhiyong Xiong; Meihai Deng
Journal:  Dig Dis Sci       Date:  2015-01-08       Impact factor: 3.199

5.  In vitro study of the effects of precore and lamivudine-resistant mutations on hepatitis B virus replication.

Authors:  Richard A Heipertz; Thomas G Miller; Colleen M Kelley; William E Delaney; Stephen A Locarnini; Harriet C Isom
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

6.  Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21.

Authors:  Yuehua Huang; Shuping Tong; Andrew W Tai; Munira Hussain; Anna S F Lok
Journal:  Gastroenterology       Date:  2011-06-24       Impact factor: 22.682

7.  Hepatitis B e-antigen persistency is associated with the properties of HBV-specific CD8 T cells in CHB patients.

Authors:  Guoping Peng; Benyan Luo; Jie Li; Dongjiu Zhao; Wei Wu; Feng Chen; Zhi Chen
Journal:  J Clin Immunol       Date:  2010-12-01       Impact factor: 8.317

8.  Evaluation of the need for treatment on 72 subjects with anti-HBe positive chronic hepatitis B.

Authors:  Shima Soleimani Amiri; Shariar Shafaee; Mohammad Reza Hasanjani Roushan; Masomeh Baiani; Mahmoud Hajiahmadi
Journal:  Caspian J Intern Med       Date:  2012

Review 9.  Core promoter: a critical region where the hepatitis B virus makes decisions.

Authors:  Jorge Quarleri
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

10.  Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis.

Authors:  X Ren; Z Xu; Y Liu; X Li; S Bai; N Ding; Y Zhong; L Wang; P Mao; F Zoulim; D Xu
Journal:  J Viral Hepat       Date:  2010-12       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.